Italia - italiano - AIFA (Agenzia Italiana del Farmaco)

koanaa healthcare gmbh - melfalan - melfalan

Italia - italiano - AIFA (Agenzia Italiana del Farmaco)

medac gesellschaft fur klinische spezialpraparate mbh - melfalan - melfalan

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

sandoz pharmaceuticals ag - lenalidomidum - capsule - lenalidomidum 2.5 mg, cellulosum microcristallinum, lactosum 33.2 mg, carmellosum natricum conexum corresp. natrium 0.089 mg, magnesii stearas, gelatina, e 171, e 172 (flavum), e 132, lacca, drucktinte: e 172 (nigrum), propylenglycolum, kalii hydroxidum, pro capsula. - onkologikum - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

sandoz pharmaceuticals ag - lenalidomidum - capsule - lenalidomidum 5 mg, cellulosum microcristallinum, lactosum 66.4 mg, carmellosum natricum conexum, natrium 0.178 mg, magnesii stearas, gelatina, e 171, drucktinte: lacca, e 172 (nigrum), propylenglycolum, kalii hydroxidum, pro capsula. - onkologikum - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

sandoz pharmaceuticals ag - lenalidomidum - capsule - lenalidomidum 7.5 mg, cellulosum microcristallinum, lactosum 99.7 mg, carmellosum natricum conexum corresp. natrium 0.266 mg, magnesii stearas, gelatina, e 171, e 172 (flavum), drucktinte: lacca, e 172 (nigrum), propylenglycolum, kalii hydroxidum, pro capsula. - onkologikum - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

sandoz pharmaceuticals ag - lenalidomidum - capsule - lenalidomidum 10 mg, cellulosum microcristallinum, lactosum 132.9 mg, carmellosum natricum conexum corresp. natrium 0.355 mg, magnesii stearas, gelatina, e 171, e 172 (flavum), e 132, drucktinte: lacca, e 172 (nigrum), propylenglycolum, kalii hydroxidum, pro capsula. - onkologikum - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

sandoz pharmaceuticals ag - lenalidomidum - capsule - lenalidomidum 15 mg, cellulosum microcristallinum, lactosum 199.3 mg, carmellosum natricum conexum corresp. natrium 0.539 mg, magnesii stearas, gelatina, e 171, e 132, drucktinte: lacca, e 172 (nigrum), propylenglycolum, kalii hydroxidum, pro capsula. - onkologikum - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

sandoz pharmaceuticals ag - lenalidomidum - capsule - lenalidomidum 20 mg, cellulosum microcristallinum, lactosum 265.8 mg, carmellosum natricum conexum corresp. natrium 0.716 mg, magnesii stearas, gelatina, e 171, e 172 (flavum), e 132, drucktinte: lacca, e 172 (nigrum), propylenglycolum, kalii hydroxidum, pro capsula. - onkologikum - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

sandoz pharmaceuticals ag - lenalidomidum - capsule - lenalidomidum 25 mg, cellulosum microcristallinum, lactosum 332.2 mg, carmellosum natricum conexum corresp. natrium 0.894 mg, magnesii stearas, gelatina, e 171, drucktinte: lacca, e 172 (nigrum), propylenglycolum, kalii hydroxidum, pro capsula. - onkologikum - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

takeda pharma ag - ixazomibum - capsule rigide - ixazomibum 2.3 mg ut ixazomibi citras, cellulosum microcristallinum, talcum, magnesii stearas, kapselhülle: gelatina, e 171, e 172 (rubrum), drucktinte: lacca, propylenglycolum, kalii hydroxidum, ammoniae solutio 30 per centum, e 172 (nigrum), pro capsula. - onkologikum - synthetika